Trial Profile
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2011
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Dyslipidaemias; Glucose intolerance; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 03 Mar 2010 Results on endothelial function have been published early online in Diabetes Care.
- 22 Sep 2009 New trial record.